These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4868713)

  • 41. [Evaluation of the effectiveness of the imuran treatment of lupus erythematosus].
    Krupko MI; Gorbunov VF; Domaseva TV
    Vestn Dermatol Venerol; 1977 Feb; (2):59-62. PubMed ID: 324171
    [No Abstract]   [Full Text] [Related]  

  • 42. Therapy of proliferative lupus glomerulonephritis: a prospective trial in The Netherlands.
    van den Wall Bake AW; Berden JH; Derksen RH; de Glas-Vos JW; Hagen EC
    Neth J Med; 1994 Dec; 45(6):280-4. PubMed ID: 7838244
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Course of nephropathy in systemic lupus erythematosus . Influence of the treatment on clinical symptoms, renal function and histology].
    Zech P; Richard P; Blanc-Brunat N; Labeeuw M; Colon S; Pozet N; Dupont E; Fries D; Traeger J
    J Urol Nephrol (Paris); 1972 Dec; 78(12):987-93. PubMed ID: 4540960
    [No Abstract]   [Full Text] [Related]  

  • 44. Effect of treatment on the evolution of renal abnormalities in lupus nephritis.
    Balow JE; Austin HA; Muenz LR; Joyce KM; Antonovych TT; Klippel JH; Steinberg AD; Plotz PH; Decker JL
    N Engl J Med; 1984 Aug; 311(8):491-5. PubMed ID: 6749206
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effects of antilymphocytic globulin on the histo-immunological lesions and on the clinical aspect of glomerular nephropathy in adults].
    Vangelista A; Stefoni S; Bonomini V
    Minerva Nefrol; 1973; 20(4):236-42. PubMed ID: 4789743
    [No Abstract]   [Full Text] [Related]  

  • 46. [Immunosuppressive therapy of systemic lupus erythematosus].
    Miescher PA; Lambert PH
    Ther Umsch; 1971 Sep; 28(9):579-85. PubMed ID: 5122520
    [No Abstract]   [Full Text] [Related]  

  • 47. [Lupus nephritis. 3: Therapeutic approach].
    Guérin S; Léveillé M
    Union Med Can; 1982 Feb; 111(2):91-5, 133. PubMed ID: 7080269
    [No Abstract]   [Full Text] [Related]  

  • 48. Treatment of systemic lupus erythematosus in childhood.
    Jacobs JC
    Arthritis Rheum; 1977 Mar; 20(2 Suppl):304-7. PubMed ID: 318122
    [No Abstract]   [Full Text] [Related]  

  • 49. Acute pancreatitis associated with long-term azathioprine therapy. Occurrence in a patient with systemic lupus erythematosus.
    Herskowitz LJ; Olansky S; Lang PG
    Arch Dermatol; 1979 Feb; 115(2):179. PubMed ID: 426524
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of a lymphocytic lymphoma during immunosuppressive therapy with azathioprine for systemic lupus erythematosus with renal involvement induced by phenylbutazone.
    Walden PA; Philalithis PE; Joekes AM; Bagshawe KD
    Clin Nephrol; 1977 Jul; 8(1):317-20. PubMed ID: 577907
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical conference: lupus erythematosus.
    Hahn BH; Avioli LV
    Arch Intern Med; 1975 Dec; 135(12):1617-21. PubMed ID: 1200732
    [No Abstract]   [Full Text] [Related]  

  • 52. Lupus nephritis: clinical course in relation to treatment.
    Nanra RS; Kincaid-Smith P
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1193-210. PubMed ID: 4803309
    [No Abstract]   [Full Text] [Related]  

  • 53. Progression from minimal or focal to diffuse proliferative lupus nephritis.
    Zimmerman SW; Jenkins PG; Shelf WD; Bloodworth JM; Burkholder PM
    Lab Invest; 1975 May; 32(5):665-72. PubMed ID: 1092911
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Results of outpatient treatment of 100 cases of systemic lupus erythematosus.
    Kardaszewicz E
    Pol Med J; 1972; 11(2):270-6. PubMed ID: 4561069
    [No Abstract]   [Full Text] [Related]  

  • 55. The course of lupus nephritis: a clinical-pathological correlation of fifty patients.
    Striker GE; Kelly MR; Quadracci LJ; Scribner BH
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1141-66. PubMed ID: 4803308
    [No Abstract]   [Full Text] [Related]  

  • 56. Comparison of azathioprine, prednisone, and heparin alone or combined in treating lupus nephritis.
    Cade R; Spooner G; Schlein E; Pickering M; DeQuesada A; Holcomb A; Juncos L; Richard G; Shires D; Levin D; Hackett R; Free J; Hunt R; Fregly M
    Nephron; 1973; 10(1):37-56. PubMed ID: 4695164
    [No Abstract]   [Full Text] [Related]  

  • 57. The application of plasmapheresis in systemic lupus erythematosus.
    Jones JV
    Prog Clin Biol Res; 1982; 106():81-9. PubMed ID: 6817336
    [No Abstract]   [Full Text] [Related]  

  • 58. Sensorineural hearing loss in systemic lupus erythematosus: case report and literature review.
    Khalidi NA; Rebello R; Robertson DD
    J Laryngol Otol; 2008 Dec; 122(12):1371-6. PubMed ID: 18282337
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Lupus erythematosus in childhood].
    Pulgram A; Zimprich H; Weippl G
    Wien Klin Wochenschr; 1973 Feb; 85(5):67-70. PubMed ID: 4685491
    [No Abstract]   [Full Text] [Related]  

  • 60. Letter: Immunosuppressive drugs in lupus nephritis.
    Epstein WV; Shearn MA
    Ann Intern Med; 1976 Apr; 84(4):492-3. PubMed ID: 1259300
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.